Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of a mesothelin-targeting logic-gated CAR T therapy in adults with solid tumors expressing mesotheli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Lung Cancer
• Mesothelioma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Rectal Cancer

Drugs mentioned

• Mesothelin-Targeting Logic-gated CAR T

Snippet

Sponsor: A2 Biotherapeutics Inc. | Conditions: Solid Tumor, Adult, Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING